logo
  

AstraZeneca : Japan Approves Koselugo For Rare Genetic Disease In Paediatric Patients

AstraZeneca (AZN.L,AZN) said that the Japanese Ministry of Health, Labour and Welfare approved Koselugo (selumetinib) for the treatment of paediatric patients three years of age and older with plexiform neurofibromas or PNs in neurofibromatosis type 1 (NF1) with clinical symptoms, such as pain and disfigurement, and PNs which cannot be completely removed by surgery without risk of substantial morbidity.

Marc Dunoyer, Chief Executive Officer, Alexion, said, "As the first medicine approved in Japan for paediatric patients with symptomatic, inoperable plexiform neurofibromas in neurofibromatosis type 1, Koselugo offers new hope for patients and families affected by this incurable genetic disease, whose only previous treatment option was repeated surgery."

The approval was based on positive results from the SPRINT Stratum 1 Phase II trial sponsored by the National Institutes of Health's National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP).

The trial showed Koselugo, an oral treatment option, reduced the size of inoperable tumours in children. Additionally, a Phase I trial in Japanese paediatric NF1 patients with symptomatic and inoperable PNs was also evaluated as a basis for the approval, with the trial showing tumour reduction.

In addition to Japan, Koselugo is also approved in the US and EU for the treatment of paediatric patients with NF1 and symptomatic, inoperable PNs. Further regulatory submissions are underway.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Salt Lake City, Utah-based Rocky Mountain Pies, LLC is recalling Red Button Vintage Creamery French Silk Pie citing possible presence of undeclared almonds, a known allergen, the U.S. Food and Drug Administration said. The recall involves 31.88 oz French Silk Pie with the lot code beginning with 2 266. Only UPC code 0 41172 81290 9 is involved in the recall. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert against Paradise Locker Meats' certain fully cooked summer sausage products. There are concerns that the products may be contaminated with extraneous materials, specifically plastic. A recall was not requested as the products are no longer available for purchase. Hormel Foods Corp. (HRL) said, in the fourth quarter, the company delivered earnings per share comparable with record results last year, which included an additional week of sales. Pretax earnings were $357 million, up 1% from a year ago. Organic net sales were up 2%, excluding the impact of an additional...
Follow RTT